News | September 14, 2009

Elekta Reports Rise in Profits to SEK 56M

September 15, 2009 – Elekta reported net sales increased by 15 percent, profit after taxes increased to SEK 56 million, and earnings per share after dilution were up to SEK 0.62 in the first three months of 2009/2010.

Demand for Elekta’s clinical solutions, products and services remained strong in. Order bookings rose by 19 percent in local currency with solid performance in all regions. Net sales grew to SEK 1,440 M and operating result rose to SEK 89 M. Earnings per share improved to SEK 0.62 from SEK 0.02.

Demand increased for aftermarket services and software. Elekta provides services dur-ing the lifetime of the product and software for efficient workflow solutions, thereby making it possible for customers to focus on patient care. We continue to grow with our over 5,000 customers - an important element for Elekta’s sustainable profitable growth.

Elekta is a leading provider of image guided radiotherapy, stereotactic radiotherapy and radiosurgery and oncology software. This year we are increasing investments in re-search and development to bring new and refined solutions to market for improved patient care and higher efficiency for healthcare providers.

At the end of July Elekta received FDA-clearance for VMAT in combination with the radiation treatment planning system Monaco. This is expected to lead to growing sales of VMAT towards the end of this year.

We are continuing to execute on our plan for geographical expansion. With a complete portfolio of products and solutions fulfilling the clinical demands, Elekta is in a strong position for future growth from new territories. In the quarter Elekta has added new partners offering financing solutions by signing agreements with Swedish Export Corporation, SEK, and Swedfund International AB. The aim is to improve availability for cancer care worldwide, and to seize the opportunities of growth for Elekta.

The economic downturn has so far had limited effect on investments in cancer care, but the uncertainty remains. It may become more difficult for private customers to obtain financing and future health care investments might be negatively affected.

Elekta’s efficiency improvement program is proceeding according to plan. Restructuring costs amounted to SEK 11 M in the quarter. Annual savings from the program are expected at SEK 100 M with full effect next fiscal year. For 2009/10 the operating costs are expected to increase by around 5 percent in local currency.

Currency markets remained volatile in the quarter. We expect positive effect on results for this fiscal year at close to SEK 250 M at present currency rates.

Elekta’s financial outlook remains unchanged of an increase in net sales by more than 8 percent in local currency, and operating profit increase in kronor of more than 35 percent. Net sales and operating profit are expected to be significantly higher in the second half of the year compared with the first.

For more information:

Related Content

Gustave Roussy, Elekta, Versa HD, linear accelerators, Mosaiq, France

Image courtesy of Elekta

News | Radiation Therapy | September 04, 2015
Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing...
ECRI Institute, linear accelerators, linac, purchase, survey
News | June 23, 2015
The ECRI Institute released a new techIQ brief on key factors to consider when purchasing a linear accelerator (linac)...
Brainlab, Exactrac, Elekta, Versa HD, LMU Medical Center, Munich
News | June 23, 2015
Brainlab announced first patient treatments in March on a fully integrated radiation oncology solution that combines...
Elekta, William Beaumont Hospital, patent lawsuit, Varian, linear accelerator
News | June 19, 2015
On June 16, 2015, William Beaumont Hospital and Elekta Ltd. filed a patent infringement suit against Varian Medical...
Brainlab, ExacTrac, Versa HD, Elekta, LMU, Munich, LINAC, first
Feature | March 24, 2015
Brainlab announced first patient treatments on a fully integrated radiation oncology solution that combines ExacTrac...
News | September 02, 2014
September 2, 2014 — In an agreement signed in Tokyo, Elekta Japan will grant Toshiba Medical Systems Corp. (TMSC) wider...
News | July 18, 2014
July 18, 2014 — Varian Medical Systems will introduce Qumulate QA, a new cloud-based QA data management and analysis...
News | June 11, 2014
June 11, 2014 — Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, announced the purchase of...
Elekta Learning and Innovation Center Atlanta ASTRO 2013 Oncology Neuroscience
News | October 02, 2013
Elekta unveiled a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th...